drugset / Trial / NCT00004487

Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux

NCT00004487 ↗

Treatment

Summary

OBJECTIVES: I. Determine the safety and efficacy of chondrocyte alginate gel suspension in pediatric patients with vesicoureteral reflux. II. Determine the long term efficacy of this treatment regimen in this patient population. III. Evaluate the short and long term avoidance of surgery or antibiotic therapy after this treatment regimen in this patient population. IV. Estimate the risk:benefit ratio of this treatment regimen in these patients.

Timeline

Start
1999-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject chondrocyte-alginate gel suspension Unknown — Other

Indications